Skip to main content
Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia flag Australia · Delayed Price · Currency is AUD
10.00
-0.16 (-1.57%)
At close: Mar 9, 2026

Clinuvel Pharmaceuticals Revenue

Clinuvel Pharmaceuticals had revenue of 36.93M AUD in the half year ending December 31, 2025, with 12.59% growth. This brings the company's revenue in the last twelve months to 96.30M, up 5.80% year-over-year. In the fiscal year ending June 30, 2025, Clinuvel Pharmaceuticals had annual revenue of 95.02M with 7.76% growth.

Revenue (ttm)
96.30M
Revenue Growth
+5.80%
P/S Ratio
5.21
Revenue / Employee
6.02M
Employees
16
Market Cap
502.01M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 202595.02M6.84M7.76%
Jun 30, 202488.18M9.86M12.59%
Jun 30, 202378.32M12.60M19.17%
Jun 30, 202265.72M17.40M36.02%
Jun 30, 202148.32M15.75M48.37%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Racura Oncology 3.48M
Immutep 7.92M
Opthea -20.12K
Dimerix 7.42M
Orthocell 9.33M
Tetratherix 2.00M
Clarity Pharmaceuticals 10.58M
PYC Therapeutics 20.56M
Revenue Rankings

Clinuvel Pharmaceuticals News

More News